Skip to main content

Annexon, Inc.

For the period ended Sep 30, 2025. Filed Nov 10, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 10, 2025

ANNX$4.21-0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share amounts)

Common Stock · AdditionalPaid-In · Accumulated OtherComprehensive · Accumulated · TotalStockholders’
SharesCostCapitalIncome (Loss)DeficitEquity
Balances as of December 31, 2024109,381,556$109$1,003,685$10$(710,699)$293,105
Exercise of stock options43,113—62——62
Restricted stock vested in the period289,735—————
Stock-based compensation——5,078——5,078
Other comprehensive loss———(101)—(101)
Net loss————(54,356)(54,356)
Balances as of March 31, 2025109,714,4041091,008,825(91)(765,055)243,788
Issuance of common stock per Employee Stock Purchase Plan purchase117,7431181——182
Stock-based compensation——4,205——4,205
Other comprehensive loss———(2)—(2)
Net loss————(49,156)(49,156)
Balances as of June 30, 2025109,832,1471101,013,211(93)(814,211)199,017
Exercise of stock options1,289—3——3
Restricted stock vested in the period53,187—————
Issuance of common stock, net of issuance costs of $6975,235,959513,487——13,492
Stock-based compensation——3,835——3,835
Other comprehensive income———17—17
Net loss————(54,922)(54,922)
Balances as of September 30, 2025115,122,582$115$1,030,536$(76)$(869,133)$161,442

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share amounts)

Common Stock · AdditionalPaid-In · Accumulated OtherComprehensive · Accumulated · TotalStockholders’
SharesCostCapital(Loss) IncomeDeficitEquity
Balances as of December 31, 202378,369,099$78$823,029$(52)$(572,499)$250,556
Exercise of stock options105,526—217——217
Issuance of common stock, net of issuance costs of $9336,639,348732,191——32,198
Exercise of pre-funded warrants5,243,4005(5)———
Restricted stock vested in the period124,695—————
Stock-based compensation——4,660——4,660
Other comprehensive loss———(50)—(50)
Net loss————(25,176)(25,176)
Balances as of March 31, 202490,482,06890860,092(102)(597,675)262,405
Exercise of stock options35,914—171——171
Issuance of common stock per Employee Stock Purchase Plan purchase98,5341214——215
Issuance of common stock, net of issuance costs of $480936,71916,125——6,126
Issuance of common stock and pre-funded warrants, net of issuance costs of $8,18313,001,12013116,804——116,817
Exercise of pre-funded warrants965,4271(1)———
Exercise of common warrants19,901—————
Stock-based compensation——4,942——4,942
Other comprehensive income———13—13
Net loss————(29,610)(29,610)
Balances as of June 30, 2024105,539,683106988,347(89)(627,285)361,079
Exercise of stock options107,467—530——530
Restricted stock vested in the period63,140—————
Stock-based compensation——4,609——4,609
Other comprehensive income———166—166
Net loss————(34,824)(34,824)
Balances as of September 30, 2024105,710,290$106$993,486$77$(662,109)$331,560
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.